Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05173974 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study to Evaluate the Maximum Maxillary Bite Force (BF) When Using Two Novel Denture Adhesives Compared to Using No-Adhesive
A Phase 3 study, sponsored by HALEON.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
NCT05173974: Completed Phase 3 study, sponsored by HALEON.
NCT05173974 is a Phase 3 study that has completed, run by HALEON. The registered enrollment target is 45 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05173974, a Phase 3 study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the hold properties of two experimental denture adhesives using established maximum incisal BF methodology.
Primary Outcome
Natural logged incisal Bite Force (BF) measurements were performed to analyze the denture dislodgement as measure of denture adhesive hold efficacy. All BF measurements were conducted by an examiner. AOB 0-12 was used to assess the incisal BF and defined as (Area under the Curve \[AUC\]0-12) divided by 12 minus baseline BF (pounds \[lbs\]). AUC was calculated from 0 to 12 hours using the trapezoid method; denoted as AUC 0-12. This transformation was carried out to return the measurement to the s
Interventions
- DEVICE Experimental Denture Adhesive 1
- DEVICE Experimental Denture Adhesive 2
- DEVICE Super Poligrip Free
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-02-08 |
| Est. Completion | 2022-07-12 |
| Phase | Phase 3 |
What the finished NCT05173974 record still lists
NCT05173974 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Experimental Denture Adhesive 1 is the first listed.
NCT05173974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05173974 about?
NCT05173974 is a clinical study titled "A Clinical Study to Evaluate the Maximum Maxillary Bite Force (BF) When Using Two Novel Denture Adhesives Compared to Using No-Adhesive". The purpose of this study is to investigate the hold properties of two experimental denture adhesives using established maximum incisal BF methodology.
What is the current status of trial NCT05173974?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2022-02-08. Estimated completion is 2022-07-12.
What interventions are being tested in trial NCT05173974?
The interventions under investigation include: Experimental Denture Adhesive 1 (DEVICE), Experimental Denture Adhesive 2 (DEVICE), Super Poligrip Free (DEVICE).
Who is sponsoring clinical trial NCT05173974?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05173974's enrollment target sits among peer trials
45 1870th of 2000 higher than 127 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI